Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
In millions, except per share items | Jun-30-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Revenues: |
Americas | 1,564.0 | 1,494.0 | 1,626.0 | 1,755.0 | 1,727.0 | 1,624.0 | 1,560.0 | 1,681.0 |
EMEA | 762.0 | 738.0 | 699.0 | 1,252.0 | 779.0 | 783.0 | 738.0 | 1,052.0 |
APAC | 638.0 | 647.0 | 627.0 | 744.0 | 720.0 | 691.0 | 648.0 | 700.0 |
Other | 743.0 | 715.0 | 755.0 | | | | | |
Total revenues | 3,707.0 | 3,594.0 | 3,707.0 | 3,514.0 | 3,226.0 | 3,098.0 | 2,946.0 | 3,181.0 |
Revenue growth [+] | 3.1% | 16.0% | 25.8% | 10.5% | 8.5% | 14.0% | 5.1% | 4.7% |
Americas | 4.7% | -8.0% | 4.2% | 4.4% | 7.5% | 10.6% | 4.1% | -8.8% |
EMEA | 3.3% | -5.7% | -5.3% | 19.0% | 8.2% | 17.0% | -2.1% | 33.3% |
APAC | -1.4% | -6.4% | -3.2% | 6.3% | 11.5% | 19.1% | 18.0% | 13.3% |
Medication Delivery | 7.2% | 1.9% | 8.3% | 5.5% | 12.3% | 15.2% | -5.5% | 3.9% |
Cost of goods sold | 2,596.0 | 2,223.0 | 2,359.0 | 2,108.0 | 1,905.0 | 1,865.0 | 1,801.0 | 1,990.0 |
Gross profit | 1,111.0 | 1,371.0 | 1,348.0 | 1,406.0 | 1,321.0 | 1,233.0 | 1,145.0 | 1,191.0 |
Gross margin | 30.0% | 38.1% | 36.4% | 40.0% | 40.9% | 39.8% | 38.9% | 37.4% |
Selling, general and administrative [+] | 964.0 | 970.0 | 1,052.0 | 885.0 | 680.0 | 675.0 | 627.0 | 650.0 |
General and administrative | | | | 885.0 | | | | 650.0 |
Research and development | 165.0 | 148.0 | 150.0 | 138.0 | 129.0 | 139.0 | 128.0 | 135.0 |
Other operating expenses | -1.0 | -11.0 | -17.0 | | | -5.0 | | |
EBITDA [+] | | 619.0 | 543.0 | 628.0 | 718.0 | | 607.0 | 619.0 |
EBITDA growth | -102.7% | 46.0% | -10.5% | 1.5% | 5.6% | -20.5% | 0.3% | -17.4% |
EBITDA margin | -0.5% | 17.2% | 14.6% | 17.9% | 22.3% | 13.7% | 20.6% | 19.5% |
Depreciation | -157.0 | 162.0 | 163.0 | 146.0 | 138.0 | -67.0 | 153.0 | 156.0 |
EBITA | 140.0 | 457.0 | 380.0 | 482.0 | 580.0 | 491.0 | 454.0 | 463.0 |
EBITA margin | 3.8% | 12.7% | 10.3% | 13.7% | 18.0% | 15.8% | 15.4% | 14.6% |
Amortization of intangibles | 157.0 | 193.0 | 217.0 | 99.0 | 68.0 | 67.0 | 64.0 | 57.0 |
EBIT [+] | -17.0 | 264.0 | 163.0 | 383.0 | 512.0 | 424.0 | 390.0 | 406.0 |
EBIT growth | -106.4% | -37.7% | -58.2% | -5.7% | 8.7% | 28.1% | -3.9% | -24.8% |
EBIT margin | -0.5% | 7.3% | 4.4% | 10.9% | 15.9% | 13.7% | 13.2% | 12.8% |
Non-recurring items | | | | | -1.0 | | | |
Interest expense, net [+] | 124.0 | 89.0 | 85.0 | -54.0 | 50.0 | 34.0 | 34.0 | -6.0 |
Interest expense | 124.0 | 89.0 | 88.0 | 128.0 | 54.0 | 37.0 | 37.0 | 112.0 |
Interest income | | | 3.0 | 182.0 | 4.0 | 3.0 | 3.0 | 118.0 |
Other income (expense), net [+] | -42.0 | 44.0 | 16.0 | -154.0 | -12.0 | 2.0 | -5.0 | -202.0 |
Other non-operating gains/losses | 3.0 | 3.0 | | | 1.0 | 4.0 | -4.0 | -2.0 |
Other | -42.0 | 44.0 | 16.0 | 56.0 | -12.0 | 6.0 | -5.0 | 222.0 |
Pre-tax income | -183.0 | 219.0 | 94.0 | 283.0 | 451.0 | 392.0 | 351.0 | 210.0 |
Income taxes | 10.0 | 34.0 | 21.0 | 41.0 | -1.0 | 91.0 | 51.0 | 39.0 |
Tax rate | | 15.5% | 22.3% | 14.5% | | 23.2% | 14.5% | 18.6% |
Minority interest | 2.0 | 3.0 | 2.0 | 4.0 | 2.0 | 3.0 | 2.0 | 3.0 |
Earnings from continuing ops | -388.0 | 182.0 | 71.0 | 238.0 | 450.0 | 298.0 | 298.0 | 168.0 |
Earnings from discontinued ops | 54.0 | 70.0 | | | | | | |
Net income | -334.0 | 252.0 | 71.0 | 238.0 | 450.0 | 298.0 | 298.0 | 168.0 |
Net margin | -9.0% | 7.0% | 1.9% | 6.8% | 13.9% | 9.6% | 10.1% | 5.3% |
|
Basic EPS [+] | ($0.77) | $0.36 | $0.14 | $0.47 | $0.90 | $0.59 | $0.59 | $0.33 |
Growth | -312.3% | -39.0% | -76.1% | 43.6% | 29.2% | 22.6% | -9.9% | -830.4% |
Diluted EPS [+] | ($0.77) | $0.36 | $0.14 | $0.47 | $0.89 | $0.59 | $0.58 | $0.32 |
Growth | -314.0% | -38.8% | -76.1% | 44.2% | 29.4% | 23.0% | -9.4% | -833.3% |
|
Dividends per share [+] | $0.29 | $0.29 | $0.28 | $0.28 | $0.28 | $0.28 | $0.25 | $0.25 |
Growth | 0.0% | 3.6% | 14.3% | 14.3% | 14.3% | 14.3% | 11.4% | 11.4% |
|
Shares outstanding (basic) [+] | 506.0 | 504.0 | 503.0 | 502.0 | 500.0 | 503.0 | 505.0 | 509.0 |
Growth | 0.4% | 0.2% | -0.4% | -1.4% | -2.2% | -1.2% | -0.4% | 0.0% |
Shares outstanding (diluted) [+] | 506.0 | 508.0 | 509.0 | 508.0 | 506.0 | 509.0 | 511.0 | 517.0 |
Growth | -0.4% | -0.2% | -0.4% | -1.7% | -2.3% | -1.5% | -1.0% | -0.4% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|